Therapeutic approaches to obesity

Expert Opinion on Therapeutic Patents

Volumn 8, Issue 12, 1998, Pages 1683-1694

  Dunlop, J ^a   Rosenzweig Lipson, S ^a  

^a PFIZER INC   (United States)

Author keywords

Neuropeptide Y; OB protein; Obesity; Pharmacological therapies; 3 adrenergic receptor

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMANTADINE DERIVATIVE; ANOREXIGENIC AGENT; ANTIOBESITY AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; DEXFENFLURAMINE; GROWTH HORMONE; LEPTIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; PROTEIN; PYRIDINE DERIVATIVE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; YOHIMBINE;

ARTICLE; BODY WEIGHT; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; LIPOLYSIS; NONHUMAN; NUTRIENT; OBESITY; SEROTONINERGIC TRANSMISSION;

EID: 0031763896     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.8.12.1683     Document Type: Article

References (31)